PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34456576-13	2021	Conclusion: GMSCs administration is a novel therapeutic strategy targeting aerobic glycolysis for the treatment of sepsis because GMSCs impair LPS-induced HMGB1 and lactate release.	gmscs	12-17	high mobility group box 1	Mus musculus	155-160	
34456576-13	2021	Conclusion: GMSCs administration is a novel therapeutic strategy targeting aerobic glycolysis for the treatment of sepsis because GMSCs impair LPS-induced HMGB1 and lactate release.	gmscs	130-135	high mobility group box 1	Mus musculus	155-160